Gradignan, France

Michel Laguerre

This inventor holds 1 USPTO granted patent. Top assignee: Societe Cortial. Active years: 1986.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michel Laguerre. Retrieved from https://idiyas.com/inventor/michel-laguerre

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 1986

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michel Laguerre: Innovator in Antimicrobial Compounds

Introduction

Michel Laguerre is a notable inventor based in Gradignan, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antimicrobial agents. His work focuses on compounds that are useful in the disinfection of healthy or injured skin and mucous membranes.

Latest Patents

Michel Laguerre holds a patent for 1-cycloalkylamino-3-t-butylamino-2-propanols. This patent describes a method of preparing a compound with the formula: ##STR1##, where n is an integer between 6 and 11, inclusive. The compounds and compositions derived from this invention are recognized for their effectiveness as antimicrobial agents.

Career Highlights

Throughout his career, Michel Laguerre has been associated with Societe Cortial, where he has contributed to various innovative projects. His expertise in the field has led to advancements in antimicrobial formulations that are crucial for medical applications.

Collaborations

Michel has collaborated with notable colleagues, including Chantal Boyer and Jean C Colleter. These partnerships have fostered a collaborative environment that enhances the development of new technologies in the pharmaceutical sector.

Conclusion

Michel Laguerre's contributions to antimicrobial compounds highlight his role as an influential inventor in the pharmaceutical industry. His innovative work continues to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…